156 research outputs found
Application of GGBFS and Bentonite to Auto-Healing Cracks of Cement Paste
Cracks are caused by many factors. Shrinkage and external loading are the most common reason. It becomes a problem when the ingression of aggressive and harmful substance penetrates to the concrete gap. This problem reduces the durability of the structures. It is well known that self â healing of cracks significantly improves the durability of the concrete structure. This paper presents self-healing cracks of cement paste containing bentonite associated with ground granulated blast furnace slag. The self-healing properties were evaluated with four parameters: crack width on the surface, crack depth, tensile strength recovery, and flexural recovery. In combination with microscopic observation, a healing process over time is also performed. The results show that bentonite improves the healing properties, in terms of surface crack width and crack depth. On the other hand, GGBFS could also improve the healing process, in terms of crack depth, direst tensile recovery, and flexural stiffness recovery. Carbonation reaction is believed as the main mechanism, which contributes the self-healing process as well as the continuous hydration progress
Kinase/phosphatase overexpression reveals pathways regulating hippocampal neuron morphology
Kinases and phosphatases that regulate neurite number versus branching versus extension are weakly correlated.The kinase family that most strongly enhances neurite growth is a family of non-protein kinases; sugar kinases related to NADK.Pathway analysis revealed that genes in several cancer pathways were highly active in enhancing neurite growth
Utilization of high-volume fly ash in pervious concrete mixtures for mangrove conservation
In environmental conservation, mangrove forests play a crucial role. Retransplanting mangrove propagules, however, faces challenges, and success rates are notably low. Achieving an optimal protector for propagules, balancing strength without impeding growth, is challenging. Mangrove propagules require a temporary protector with an optimal balance, neither too weak nor too strong, to shield them from current waves which is difficult. We propose using pervious concrete pots with high-volume fly ash activated with low NaOH concentrations. The investigation focuses on the influence of the mixing procedure on workability, compressive strength, and mineral composition. The novel discovery in this study is the specific sequence of stirring the ingredients using an alkali activator, which adds an interesting dimension to the research. It is recommended to adopt Sequence 2 in pervious concrete production, where NaOH dissolved FA in the mixture forming albite as N-A-S-H gel product. It surely enhanced both workability and the strength confirming uniform application processes. The two recommended variants, PFS-60 and PFBS-50, effectively utilize coal ash, meeting the target compressive strength range of 3â5âŻMPa and providing support for mangrove pots over a 3â4 year period. Notably, both compositions maintained consistent mechanical properties during exposure to tidal conditions for 240 days.They exhibit high permeability (694âŻliter/m²/minute), facilitating efficient water passage without sediment entrainment
Survival of a cohort of patients with Intermediate and advanced gall bladder cancer treated with a prospective therapeutic protocol
Retraction Note: Ulnar malignant peripheral nerve sheath tumour diagnosis in a mixed-breed dog as a model to study human: histologic, immunohistochemical, and clinicopathologic study
Activation of TORC1 transcriptional coactivator through MEKK1-induced phosphorylation
CREB is a prototypic bZIP transcription factor and a master regulator of glucose metabolism, synaptic plasticity, cell growth, apoptosis, and tumorigenesis. Transducers of regulated CREB activity (TORCs) are essential transcriptional coactivators of CREB and an important point of regulation on which various signals converge. In this study, we report on the activation of TORC1 through MEKK1-mediated phosphorylation. MEKK1 potently activated TORC1, and this activation was independent of downstream effectors MEK1/MEK2, ERK2, JNK, p38, protein kinase A, and calcineurin. MEKK1 induced phosphorylation of TORC1 both in vivo and in vitro. Expression of the catalytic domain of MEKK1 alone in cultured mammalian cells sufficiently caused phosphorylation and subsequent activation of TORC1. MEKK1 physically interacted with TORC1 and stimulated its nuclear translocation. An activation domain responsive to MEKK1 stimulation was mapped to amino acids 431-650 of TORC1. As a physiological activator of CREB, interleukin 1ι triggered MEKK1-dependent phosphorylation of TORC1 and its consequent recruitment to the cAMP response elements in the interleukin 8 promoter. Taken together, our findings suggest a new mechanism for regulated activation of TORC1 transcriptional coactivator and CREB signaling. Š 2008 by The American Society for Cell Biology.published_or_final_versio
Crystal Structures of Two Aminoglycoside Kinases Bound with a Eukaryotic Protein Kinase Inhibitor
Antibiotic resistance is recognized as a growing healthcare problem. To address this issue, one strategy is to thwart the causal mechanism using an adjuvant in partner with the antibiotic. Aminoglycosides are a class of clinically important antibiotics used for the treatment of serious infections. Their usefulness has been compromised predominantly due to drug inactivation by aminoglycoside-modifying enzymes, such as aminoglycoside phosphotransferases or kinases. These kinases are structurally homologous to eukaryotic Ser/Thr and Tyr protein kinases and it has been shown that some can be inhibited by select protein kinase inhibitors. The aminoglycoside kinase, APH(3â˛)-IIIa, can be inhibited by CKI-7, an ATP-competitive inhibitor for the casein kinase 1. We have determined that CKI-7 is also a moderate inhibitor for the atypical APH(9)-Ia. Here we present the crystal structures of CKI-7-bound APH(3â˛)-IIIa and APH(9)-Ia, the first structures of a eukaryotic protein kinase inhibitor in complex with bacterial kinases. CKI-7 binds to the nucleotide-binding pocket of the enzymes and its binding alters the conformation of the nucleotide-binding loop, the segment homologous to the glycine-rich loop in eurkaryotic protein kinases. Comparison of these structures with the CKI-7-bound casein kinase 1 reveals features in the binding pockets that are distinct in the bacterial kinases and could be exploited for the design of a bacterial kinase specific inhibitor. Our results provide evidence that an inhibitor for a subset of APHs can be developed in order to curtail resistance to aminoglycosides
Protein Signature of Lung Cancer Tissues
Lung cancer remains the most common cause of cancer-related mortality. We applied a highly multiplexed proteomic technology (SOMAscan) to compare protein expression signatures of non small-cell lung cancer (NSCLC) tissues with healthy adjacent and distant tissues from surgical resections. In this first report of SOMAscan applied to tissues, we highlight 36 proteins that exhibit the largest expression differences between matched tumor and non-tumor tissues. The concentrations of twenty proteins increased and sixteen decreased in tumor tissue, thirteen of which are novel for NSCLC. NSCLC tissue biomarkers identified here overlap with a core set identified in a large serum-based NSCLC study with SOMAscan. We show that large-scale comparative analysis of protein expression can be used to develop novel histochemical probes. As expected, relative differences in protein expression are greater in tissues than in serum. The combined results from tissue and serum present the most extensive view to date of the complex changes in NSCLC protein expression and provide important implications for diagnosis and treatment
P53 in human melanoma fails to regulate target genes associated with apoptosis and the cell cycle and may contribute to proliferation
<p>Abstract</p> <p>Background</p> <p>Metastatic melanoma represents a major clinical problem. Its incidence continues to rise in western countries and there are currently no curative treatments. While mutation of the <it>P53 </it>tumour suppressor gene is a common feature of many types of cancer, mutational inactivation of <it>P53 </it>in melanoma is uncommon; however, its function often appears abnormal.</p> <p>Methods</p> <p>In this study whole genome bead arrays were used to examine the transcript expression of P53 target genes in extracts from 82 melanoma metastases and 6 melanoma cell lines, to provide a global assessment of aberrant P53 function. The expression of these genes was also examined in extracts derived from diploid human melanocytes and fibroblasts.</p> <p>Results</p> <p>The results indicated that P53 target transcripts involved in apoptosis were under-expressed in melanoma metastases and melanoma cell lines, while those involved in the cell cycle were over-expressed in melanoma cell lines. There was little difference in the transcript expression of P53 target genes between cell lines with null/mutant <it>P53 </it>compared to those with wild-type <it>P53</it>, suggesting that altered expression in melanoma was not related to <it>P53 </it>status. Similarly, down-regulation of P53 by short-hairpin RNA (shRNA) had limited effect on P53 target gene expression in melanoma cells, whereas there were a large number of P53 target genes whose mRNA expression was significantly altered by P53 inhibition in melanocytes. Analysis of whole genome gene expression profiles indicated that the ability of P53 to regulate genes involved in the cell cycle was significantly reduced in melanoma cells. Moreover, inhibition of P53 in melanocytes induced changes in gene expression profiles that were characteristic of melanoma cells and resulted in increased proliferation. Conversely, knockdown of P53 in melanoma cells resulted in decreased proliferation.</p> <p>Conclusions</p> <p>These results indicate that P53 target genes involved in apoptosis and cell cycle regulation are aberrantly expressed in melanoma and that this aberrant functional activity of P53 may contribute to the proliferation of melanoma.</p
- âŚ